0000899243-22-007492.txt : 20220223
0000899243-22-007492.hdr.sgml : 20220223
20220223194016
ACCESSION NUMBER: 0000899243-22-007492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220220
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sprague John M
CENTRAL INDEX KEY: 0001730056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 22665803
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-20
0
0001492674
T2 Biosystems, Inc.
TTOO
0001730056
Sprague John M
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Common Stock
2022-02-21
4
M
0
10000
A
55414
D
Common Stock
2022-02-21
4
F
0
3775
0.466
D
45485
D
Restricted Stock Units
2022-02-20
4
A
0
600000
0.00
A
Common Stock
600000
600000
D
Restricted Stock Units
2022-02-21
4
M
0
10000
0.00
D
Common Stock
10000
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Includes 3,968 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on May 15, 2021 and 5,961 shares acquired under the ESPP on November 15, 2021.
3,775 shares of common stock were automatically withheld at vesting to cover required tax withholding.
On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal installments commencing on February 20, 2023.
On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.
/s/ Michael Gibbs, Attorney-in-fact
2022-02-23